Latest Distribution Partnerships News

Page 1 of 9
Medical Developments International (MVP) reported an 8% revenue increase driven by strong Penthrox growth, despite a slight EBIT loss impacted by foreign exchange. The company advances pediatric approvals and targets further volume gains.
Ada Torres
Ada Torres
19 Feb 2026
Goodman Group reported a slight dip in operating profit for the half year ended 31 December 2025, while statutory profit rose and the total portfolio value expanded to $87.4 billion. The group maintained its interim distribution at 15 cents per security amid ongoing investment in logistics and digital infrastructure.
Eva Park
Eva Park
19 Feb 2026
Australian Vintage reports steady first-half sales and outlines a robust strategy focused on innovation, portfolio diversification, and global expansion to meet full-year growth targets.
Victor Sage
Victor Sage
19 Feb 2026
RLF AgTech has secured strategic distribution partnerships with two leading Indian agricultural groups, marking its commercial entry into one of the world’s largest crop nutrition markets. These agreements position RLF for rapid expansion in India’s vast and growing agricultural sector.
Ada Torres
Ada Torres
19 Feb 2026
Rhythm Biosciences reported a $2.26 million half-year loss as it advances ColoSTAT into commercialisation and expands geneType partnerships, signalling a pivotal phase for the ASX-listed medical diagnostics company.
Ada Torres
Ada Torres
18 Feb 2026
The week was split between big earnings reactions and small-cap rocks-and-rigs rallies. Pro Medicus sank despite record numbers, while a handful of explorers jumped on fresh discoveries and policy wins.
Logan Eniac
Logan Eniac
14 Feb 2026
Healthcare stocks split into two stories this week: big names sold off hard, while a few small caps ran on clear news. The biggest moves came from a sharp fall in Pro Medicus and Cochlear, while Noxopharm jumped after a top-tier journal publication.
Logan Eniac
Logan Eniac
14 Feb 2026
Osteopore Limited has secured an exclusive three-year distribution deal with Medprin Biotech GmbH to broaden its presence in Latin America's craniofacial reconstruction market, tapping into a region poised for significant growth.
Ada Torres
Ada Torres
13 Feb 2026
Oakridge International Limited has reported a striking turnaround in its half-year results, posting a profit after tax of $172,239 against a prior loss, driven by strong sales and product innovation in healthcare technology.
Victor Sage
Victor Sage
11 Feb 2026
ECS Botanics has partnered with Nimbus Health to distribute its medicinal cannabis products across Germany, marking its entry into Europe's largest cannabis market. The launch of the OzSun brand is set for April 2026, with premium Terphogz strains to follow later in the year.
Ada Torres
Ada Torres
11 Feb 2026
A single diagnostics update sparked a breakout week, while a handful of biotech names sold off hard despite busy newsflow. Capital raisings, takeover steps and US market pushes kept healthcare in motion heading into mid-February milestones.
Logan Eniac
Logan Eniac
7 Feb 2026
Aroa Biosurgery’s latest business update reveals promising clinical outcomes from its Myriad trauma study and evolving reimbursement policies that could reshape its market position. The company also projects solid revenue growth for FY26, supported by strategic commercial initiatives.
Ada Torres
Ada Torres
3 Feb 2026